60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP NASDAQ) stock market data APIs
$1.4476
0(0%)
as of September 17, 2025
Try our APIs with
free plan!
60 Degrees Pharmaceuticals, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria preventative treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. The company was founded in 2010 and is headquartered in Washington, District Of Columbia.
Prev. Close
1.4476
Open
1.4476
High
1.4591
Low
1.4237
52 wk Range
1.215-12.45
Market Cap
5 910 K
P/E Ratio
20.5714
Shares Outstanding
4 104 K
Revenue
984 K
EPS
-1.16
Beta
2.729
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get 60 Degrees Pharmaceuticals, Inc. Common Stock data using free add-ons & libraries
Get 60 Degrees Pharmaceuticals, Inc. Common Stock Fundamental Data
60 Degrees Pharmaceuticals, Inc. Common Stock Fundamental data includes:
- Net Revenue: 984 K
- EBITDA: -7 632 355
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get 60 Degrees Pharmaceuticals, Inc. Common Stock Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: 2025-08-13
- EPS/Forecast: -0.1
Get 60 Degrees Pharmaceuticals, Inc. Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
60 Degrees Pharmaceuticals, Inc. Common Stock News
New
60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference
WASHINGTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing n...
60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis
90-day trial measuring change in general fatigue in chronic babesiosis patientsEnrollment expected to commence Q4 2025 and to be completed by Q2 2026Site has clinical expertise in infectious disease t...
60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results
A now resolved supply disruption led to Q2 net product revenue decline but higher profitability due to increased usage of a cash-pay distribution model$1.97 million cash on hand, runway through March ...
60 Degrees Pharmaceuticals announces pricing of up to $10 million public offering
* 60 Degrees Pharmaceuticals (NASDAQ:SXTP [https://seekingalpha.com/symbol/SXTP]) announced on Tuesday the pricing of a public offering of 2.63 million shares of the company’s common stock and acc...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
